Cargando…

Increased Risk of Arrhythmia in COVID-19 Patients: Possible Roles of Both the Disease Pathophysiology and Adverse Drug Reactions

Detalles Bibliográficos
Autor principal:	Rismanbaf, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808179/ https://www.ncbi.nlm.nih.gov/pubmed/33489988 http://dx.doi.org/10.4103/jrpp.JRPP_20_63

Ejemplares similares

Insomnia drug therapy in COVID-19 patients; a letter to editor
por: Rismanbaf, Ali
Publicado: (2020)

Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor
por: Rismanbaf, Ali, et al.
Publicado: (2020)

Social Media as a Double-Edged Sword: Lessons from COVID-19 Outbreak
por: Rismanbaf, Ali
Publicado: (2021)

The Necessity of an Aseptic Environment for the Preparation of Enteral Feeding Solutions in Iranian Hospitals
por: Rismanbaf, Ali
Publicado: (2020)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Diagnostic Dilemmas for Underlying Pathophysiology of Arrhythmias Originating from the Right Ventricle
por: Cay, Serkan, et al.
Publicado: (2014)

COVID-19 and risk of arrhythmia?
por: Matos Bela, Margarida, et al.
Publicado: (2020)

Adverse drug reaction and causality assessment scales
por: Zaki, Syed Ahmed
Publicado: (2011)

Clinical causality assessment for adverse drug reactions
por: Parida, Satyen
Publicado: (2013)

Adverse drug reaction monitoring in psychiatry out-patient
por: Tandon, Vishal
Publicado: (2012)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
por: Ilias, Ioannis, et al.
Publicado: (2020)

Adverse drug reactions due to ophthalmic drugs: Reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Adverse drug reactions of itolizumab in COVID-19 patient: A case report
por: Mohammed, Ziauddin, et al.
Publicado: (2022)

Synthetic cannabinoids and potential cardiac arrhythmia risk: an important message for drug users
por: Hancox, Jules C., et al.
Publicado: (2020)

Drug-induced arrhythmia: Are we cautious enough?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

Incident Reporting of Adverse Drug Reaction to Intravenous Ranitidine in an Emergency Department
por: Sud, Saurabh, et al.
Publicado: (2018)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse drug reactions with naltrexone: Experience from an addiction treatment center
por: Sarkar, Siddharth, et al.
Publicado: (2021)

Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome
por: Ashtari, Fereshteh, et al.
Publicado: (2021)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

System of adverse drug reactions reporting: What, where, how, and whom to report?
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2015)

Adverse reactions to nonsteroidal anti-inflammatory drugs and hypersensitivity to lipid transfer proteins
por: Nucera, Eleonora, et al.
Publicado: (2016)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Discouraging adverse drug reactions reporting culture: Just a tip of the ‘Gullible Prescribing’
por: Mohammed, Imran
Publicado: (2013)

Proposal for Publishing and Parallel Reporting of Case Reports on Adverse Drug Reactions to Authorities by Physicians
por: Sickmüller, Barbara, et al.
Publicado: (2013)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Sudden increased blood pressure and flu like symptom: An acute adverse reaction to nimotuzumab administration
por: Chaiyasit, Kamon, et al.
Publicado: (2013)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Tramadol-Related Adverse Drug Reactions at an Addiction Psychiatry Setting: A Cross-Sectional Analysis
por: Dhagudu, Naveen Kumar, et al.
Publicado: (2019)

COVID‐19 and new‐onset arrhythmia
por: Singh, Sandeep, et al.
Publicado: (2020)

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Arrhythmogenic Right Ventricle in Left Ventricular Non-compaction - In Response to the Letter to the Editor "Diagnostic Dilemmas for Underlying Pathophysiology of Arrhythmias Originating from the Right Ventricle"
por: Honarbakhsh, Shohreh, et al.
Publicado: (2014)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
por: Khan, Zakir, et al.
Publicado: (2022)

Post-Spinal Headache: A New Possible Pathophysiology
por: Shahriari, Ali, et al.
Publicado: (2016)

Arrhythmias in prone position
por: Borthakur, Biplob, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t016k2oreak38rdeusqsp5s5md